Previous close | 448.60 |
Open | 452.00 |
Bid | 445.00 x 0 |
Ask | 445.45 x 0 |
Day's range | 443.00 - 455.40 |
52-week range | 359.40 - 546.10 |
Volume | |
Avg. volume | 361,011 |
Market cap | 2.319T |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | 20.72 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.00 (0.22%) |
Ex-dividend date | 24 Jan 2024 |
1y target est | N/A |
(Bloomberg) -- Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here.Most Read from BloombergDubai Grinds to Standstill as Cloud Seeding Worsens FloodingRed Lobster Considers Bankruptcy to Deal With Leases and Labor CostsTesla Asks Investors to Approve Musk’s $56 Billion Pay AgainElon Wants His Money BackBankers Hit With Millions in Breakup Fees for Ditching New JobsInfosys Ltd. and Wipro Ltd.’s commentary and f
Wipro GE Healthcare, a joint venture of India's Wipro Enterprises and a wholly owned entity of U.S.-based GE Healthcare, said it would invest 80 billion rupees ($960 million) in the country in its manufacturing and research and development facilities. Bengaluru-based medical technology company Wipro GE Healthcare said on Tuesday the investment would be done over the next five years to boost local manufacturing as it focuses on growing its footprint in the country in line with the government's "Make in India" initiative.
Nutanix (NTNX) expands its partnership with Wipro to introduce a new business unit focused on NTNX's technologies.